Literature DB >> 11159930

Mood stabilizers and ion regulation.

R S El-Mallakh1, M O Huff.   

Abstract

Understanding the pathogenesis and pathophysiology of bipolar disorder is a prerequisite for accelerating the development of effective therapeutic agents and interventions. One of the best clues to these processes lies in shared mechanisms of action of mood-stabilizing agents. All effective mood stabilizers share the ability to attenuate the influx and intracellular accumulation of sodium in an activity-dependent manner. When coupled with independent observations of aberrant ion regulation in mania and bipolar depression, this shared characteristic is potentially significant. A unified hypothesis is presented in which lithium, valproic acid, and carbamazepine are suggested to produce antimanic effects by modifying ion flux and intracellular ion concentrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159930     DOI: 10.1080/10673220127873

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  12 in total

1.  Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors.

Authors:  Jill K Countryman; Lyndle Gradoville; George Miller
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

2.  Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures.

Authors:  Martin E Brown; Rif S El-Mallakh
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

3.  Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Authors:  Brent P Forester; Chelsea T Finn; Yosef A Berlow; Megan Wardrop; Perry F Renshaw; Constance M Moore
Journal:  Bipolar Disord       Date:  2008-09       Impact factor: 6.744

4.  Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.

Authors:  Arun Ravindran; Peter Silverstone; Denis Lacroix; Erno van Schaick; An Vermeulen; Jennifer Alexander
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Connection between genetic and clinical data in bipolar disorder.

Authors:  Erling Mellerup; Ole Andreassen; Bente Bennike; Henrik Dam; Srdjan Djurovic; Srdjan Durovic; Thomas Hansen; Ingrid Melle; Gert Lykke Møller; Ole Mors; Pernille Koefoed
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

Review 6.  Role of endogenous ouabain in the etiology of bipolar disorder.

Authors:  Rif S El-Mallakh; Yonglin Gao; Pan You
Journal:  Int J Bipolar Disord       Date:  2021-02-01

Review 7.  Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art.

Authors:  Rif S El-Mallakh; Vishnu Priya Sampath; Noa Horesh; David Lichtstein
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

8.  Current and emerging therapies for the management of bipolar disorders.

Authors:  Rif S El-Mallakh; Ahmed Z Elmaadawi; Yonglin Gao; Kavita Lohano; R Jeannie Roberts
Journal:  J Cent Nerv Syst Dis       Date:  2011-08-07

9.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

10.  A review of potassium channels in bipolar disorder.

Authors:  Jennifer T Judy; Peter P Zandi
Journal:  Front Genet       Date:  2013-06-11       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.